BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 1777606)

  • 1. Modified CHOP in an aged patient with non-Hodgkin's lymphoma and probable extensive pulmonary involvement.
    Asano Y; Ohshima K; Yoshizawa S; Shiraishi G; Kato K
    Int J Hematol; 1991 Aug; 54(4):327-9. PubMed ID: 1777606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
    Mohammad RM; Wall NR; Dutcher JA; Al-Katib AM
    Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck.
    Nishioka T; Tsuchiya K; Nishioka S; Kitahara T; Ohmori K; Homma A; Aoyma H; Shindoh M; Shirato H
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):847-52. PubMed ID: 15465202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical resection combined with CHOP chemotherapy plus rituximab for a patient with advanced mesenteric diffuse large B cell lymphoma.
    Yamaguchi T; Takahashi H; Kagawa R; Takeda R; Sakata S; Nishizaki D; Takamatsu T; Iwasa Y
    Hepatogastroenterology; 2008; 55(84):891-4. PubMed ID: 18705290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Modified CHOP and radiation therapy in an aged patient with angioendothelial lymphoma].
    Hisano C; Asano Y; Ohe K; Matsubara F; Okamoto O; Shiraishi G; Okubo H
    Rinsho Ketsueki; 1994 May; 35(5):506-10. PubMed ID: 8028199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse large B-cell lymphoma with fibrillary matrix.
    Dargent JL; Meiers I; Lespagnard L; Ma Y; Dehou MF; Verhest A
    Diagn Cytopathol; 2002 Oct; 27(4):223-6. PubMed ID: 12357500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Occurrence of follicular small cleaved cell lymphoma following chemotherapy for diffuse large cell lymphoma].
    Saito S; Hayashi K; Ohnoshi T; Kawashima K; Matsutomo S; Tagawa S; Yoshino T; Nishiuchi R; Kimura I
    Rinsho Ketsueki; 1994 Jul; 35(7):676-81. PubMed ID: 8065020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Destructive midline palatal lesion.
    Loudon JA; Marsh WL; Allen CM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Feb; 89(2):134-6. PubMed ID: 10673645
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
    Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
    Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of pulmonary intravascular lymphoma treated with CHOP chemotherapy plus rituximab].
    Ohkubo H; Yoshida T; Ohta K; Takaku T; Katagiri T; Paku J; Kasuga I; Minemura K; Gotoh A; Serizawa H; Mukai K; Ohyashiki K
    Gan To Kagaku Ryoho; 2005 Apr; 32(4):553-6. PubMed ID: 15853227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary hepatic non-Hodgkin's lymphoma].
    De la Maya MD; Escalante R; Torre A; Urdambidelus C
    Sangre (Barc); 1999 Jun; 44(3):242. PubMed ID: 10481592
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison between R-CHOP regimen and CHOP regimen in treating naive diffuse large B-cell lymphoma in China--a multi-center randomized trail].
    Lin TY; Zhang HY; Huang Y; Guan ZZ; Shen T; Shi YK; Zhu J; Ke XY; Wang HQ; Shen ZX; Yu SY; Liu T; Shi XL
    Ai Zheng; 2005 Dec; 24(12):1421-6. PubMed ID: 16351785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Concurrent chemo-radiotherapy for localized refractory non-Hodgkin's lymphoma--report of two cases].
    Sugimoto T; Matano S; Nishijima H; Kakuta K; Inamura K; Okamura T; Munemoto S; Satoh S
    Gan To Kagaku Ryoho; 2007 Jan; 34(1):125-8. PubMed ID: 17220687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience.
    Escalón MP; Liu NS; Yang Y; Hess M; Walker PL; Smith TL; Dang NH
    Cancer; 2005 May; 103(10):2091-8. PubMed ID: 15816054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Hodgkin's lymphoma (diffuse large B cell lymphoma).
    Copson E
    Clin Evid; 2005 Jun; (13):1-18. PubMed ID: 16135258
    [No Abstract]   [Full Text] [Related]  

  • 16. CD5+ T-cell/histiocyte-rich large B-cell lymphoma.
    Chang CC; Bunyi-Teopengco E; Eshoa C; Chitambar CR; Kampalath B
    Mod Pathol; 2002 Oct; 15(10):1051-7. PubMed ID: 12379751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successfully-treated mesenteric non-Hodgkin's lymphoma involving hepatic mass--a case report.
    Yamaguchi T; Takahashi H; Kagawa R; Takeda R; Sakata S; Yamamoto M; Nishizaki D; Takamatsu T; Iwasa Y
    Gan To Kagaku Ryoho; 2007 May; 34(5):783-7. PubMed ID: 17496458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multiple myeloma in a patient in remission from malignant lymphoma].
    Hashimoto S; Kawano E; Hirasawa A; Morio S; Aotuka N; Nakamura H; Oh H; Itoh K; Asai T; Yoshida S
    Rinsho Ketsueki; 1992 May; 33(5):671-6. PubMed ID: 1630019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recombinant G-CSF and the interstitial pneumonia during MACOP-B therapy in two cases of non-Hodgkin's lymphoma].
    Okubo Y; Nakazawa K
    Rinsho Ketsueki; 1993 Apr; 34(4):473-7. PubMed ID: 7685433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Primary cardiac non-Hodgkin's lymphoma].
    Yamaguchi Y; Dobashi N; Usui N; Kobayashi T; Nakamura T; Takasaki N; Kato A; Watanabe H; Saito T; Tajima N; Kuraishi Y
    Rinsho Ketsueki; 1998 Apr; 39(4):297-301. PubMed ID: 9597897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.